|
2024
|
Invention
|
Solid dispersion forms of rifaximin.
Provided herein are solid dispersions comprising rifaximin ... |
|
|
Invention
|
Methods of treating hepatic encephalopathy.
The application describes treatment of hepatic encep... |
|
|
Invention
|
Methods for treating irritable bowel syndrome (ibs).
The present invention provides new methods ... |
|
2023
|
P/S
|
Promoting public awareness of opioid-induced constipation and treatment of opioid-induced constip... |
|
2022
|
P/S
|
Pharmaceutical preparations, namely, drugs to treat opioid-induced constipation. |
|
|
Invention
|
Use of methylnaltrexone to attenuate tumor progression.
Presented herein are methods for prevent... |
|
|
Invention
|
Methods for treating irritable bowel syndrome (ibs). The present invention provides new methods a... |
|
2021
|
Invention
|
Solid dispersion forms of rifaximin. Provided herein are solid dispersions comprising rifaximin a... |
|
|
P/S
|
providing medical information in the nature of medical information for professionals, patients, c... |
|
|
Invention
|
Methods of treating hepatic encephalopathy. The application describes treatment of hepatic enceph... |
|
2020
|
Invention
|
Formulations of rifaximin and uses thereof.
The present invention relates to new rifaximin forms... |
|
|
Invention
|
Methods for retreating irritable bowel syndrome (ibs).
The present invention provides new method... |
|
2019
|
Invention
|
Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome.
A method for the trea... |
|
2018
|
Invention
|
Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome. A method for the treat... |
|
2016
|
Invention
|
Methods for retreating irritable bowel syndrome (ibs). The present invention provides new methods... |
|
|
Invention
|
Ibs microbiota and uses thereof. The instant application provides methods of diagnosing and treat... |
|
|
Invention
|
Forms of rifaximin and uses thereof. The present invention relates to Rifaximin amorphous forms, ... |
|
|
Invention
|
Balsalazide formulations and manufacture and use thereof.
The invention relates to formulations ... |
|
2015
|
Invention
|
Use of methylnaltrexone to attenuate tumor progression. Presented herein are methods for preventi... |
|
|
Invention
|
Hydroxy-(r),(r)-2,2'-bismethylnaltrexones and uses thereof. The present application relates to co... |
|
|
Invention
|
Methods for treating bowel diseases.
The present invention provides new methods of treating bowe... |
|
|
Invention
|
Methods of administering methylnaltrexone. Provided herein are methods of decreasing the risk of ... |
|
2013
|
P/S
|
prescription pharmaceutical preparations for the treatment and prevention of gastrointestinal dis... |
|
2006
|
P/S
|
Pharmaceutical preparation, namely, a drug to treat opioid-induced constipation |
|
|
P/S
|
Pharmaceutical preparations, namely a drug to reverse and treat the side effects of opioids. |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases |
|
2001
|
P/S
|
Pharmaceutical preparations and substances for the treatment and/or alleviation of gastrointestin... |
|
2000
|
P/S
|
PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISEASES |
|
1997
|
P/S
|
topical preparation for treatment of inflammatory and pruritic dermatoses |
